Pludowski Pawel, Holick Michael F, Grant William B, Konstantynowicz Jerzy, Mascarenhas Mario R, Haq Afrozul, Povoroznyuk Vladyslav, Balatska Nataliya, Barbosa Ana Paula, Karonova Tatiana, Rudenka Ema, Misiorowski Waldemar, Zakharova Irina, Rudenka Alena, Łukaszkiewicz Jacek, Marcinowska-Suchowierska Ewa, Łaszcz Natalia, Abramowicz Pawel, Bhattoa Harjit P, Wimalawansa Sunil J
Department of Biochemistry, Radioimmunology and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland.
Boston University Medical Center, 85 East Newton Street M-1033, Boston, MA 02118, USA.
J Steroid Biochem Mol Biol. 2018 Jan;175:125-135. doi: 10.1016/j.jsbmb.2017.01.021. Epub 2017 Feb 12.
Research carried out during the past two-decades extended the understanding of actions of vitamin D, from regulating calcium and phosphate absorption and bone metabolism to many pleiotropic actions in organs and tissues in the body. Most observational and ecological studies report association of higher serum 25-hydroxyvitamin D [25(OH)D] concentrations with improved outcomes for several chronic, communicable and non-communicable diseases. Consequently, numerous agencies and scientific organizations have developed recommendations for vitamin D supplementation and guidance on optimal serum 25(OH)D concentrations. The bone-centric guidelines recommend a target 25(OH)D concentration of 20ng/mL (50nmol/L), and age-dependent daily vitamin D doses of 400-800IU. The guidelines focused on pleiotropic effects of vitamin D recommend a target 25(OH)D concentration of 30ng/mL (75nmol/L), and age-, body weight-, disease-status, and ethnicity dependent vitamin D doses ranging between 400 and 2000IU/day. The wise and balanced choice of the recommendations to follow depends on one's individual health outcome concerns, age, body weight, latitude of residence, dietary and cultural habits, making the regional or nationwide guidelines more applicable in clinical practice. While natural sources of vitamin D can raise 25(OH)D concentrations, relative to dietary preferences and latitude of residence, in the context of general population, these sources are regarded ineffective to maintain the year-round 25(OH)D concentrations in the range of 30-50ng/mL (75-125nmol/L). Vitamin D self-administration related adverse effects, such as hypercalcemia and hypercalciuria are rare, and usually result from taking extremely high doses of vitamin D for a prolonged time.
过去二十年开展的研究拓展了对维生素D作用的认识,从调节钙和磷的吸收以及骨代谢,到在体内各器官和组织中发挥多种多效性作用。大多数观察性和生态学研究报告称,较高的血清25-羟基维生素D [25(OH)D] 浓度与几种慢性、传染性和非传染性疾病的较好预后相关。因此,众多机构和科学组织已制定了维生素D补充建议以及关于最佳血清25(OH)D浓度的指南。以骨骼为中心的指南建议25(OH)D浓度目标为20ng/mL(50nmol/L),以及根据年龄而定的每日400 - 800IU的维生素D剂量。关注维生素D多效性作用的指南建议25(OH)D浓度目标为30ng/mL(75nmol/L),以及根据年龄、体重、疾病状态和种族而定的每日400至2000IU不等的维生素D剂量。明智且平衡地选择遵循的建议取决于个人对健康结果的关注、年龄、体重、居住纬度、饮食和文化习惯,这使得地区性或全国性指南在临床实践中更具适用性。虽然维生素D的天然来源可提高25(OH)D浓度,但相对于饮食偏好和居住纬度而言,在一般人群中,这些来源被认为无法有效维持全年25(OH)D浓度在30 - 50ng/mL(75 - 125nmol/L)范围内。与自行服用维生素D相关的不良反应,如高钙血症和高钙尿症较为罕见,通常是由于长时间服用极高剂量的维生素D所致。